Latest & greatest articles for insomnia

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on insomnia or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on insomnia and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for insomnia

181. Adaptive Servo-Ventilation for Central Sleep Apnea in Heart Failure. Full Text available with Trip Pro

Adaptive Servo-Ventilation for Central Sleep Apnea in Heart Failure. 26886532 2016 02 19 2018 12 02 1533-4406 374 7 2016 02 18 The New England journal of medicine N. Engl. J. Med. Adaptive Servo-Ventilation for Central Sleep Apnea in Heart Failure. 689 10.1056/NEJMc1515007 Yamauchi Motoo M Combs Daniel D Parthasarathy Sairam S eng Letter Comment United States N Engl J Med 0255562 0028-4793 AIM IM N Engl J Med. 2015 Sep 17;373(12):1095-105 26323938 N Engl J Med. 2016 Feb 18;374(7):690-1 26886528 (...) Cardiovascular Diseases mortality Female Heart Failure, Systolic complications Humans Male Positive-Pressure Respiration methods Sleep Apnea, Central therapy 2016 2 18 6 0 2016 2 18 6 0 2016 2 20 6 0 ppublish 26886532 10.1056/NEJMc1515007 10.1056/NEJMc1515007#SA4

2016 NEJM

182. Adaptive Servo-Ventilation for Central Sleep Apnea in Heart Failure. Full Text available with Trip Pro

Adaptive Servo-Ventilation for Central Sleep Apnea in Heart Failure. 26886533 2016 02 19 2018 12 02 1533-4406 374 7 2016 02 18 The New England journal of medicine N. Engl. J. Med. Adaptive Servo-Ventilation for Central Sleep Apnea in Heart Failure. 689 10.1056/NEJMc1515007 Bradley T Douglas TD Floras John S JS eng Letter Comment United States N Engl J Med 0255562 0028-4793 AIM IM N Engl J Med. 2015 Sep 17;373(12):1095-105 26323938 N Engl J Med. 2016 Feb 18;374(7):690-1 26886528 Cardiovascular (...) Diseases mortality Female Heart Failure, Systolic complications Humans Male Positive-Pressure Respiration methods Sleep Apnea, Central therapy 2016 2 18 6 0 2016 2 18 6 0 2016 2 20 6 0 ppublish 26886533 10.1056/NEJMc1515007 10.1056/NEJMc1515007#SA5

2016 NEJM

183. Adaptive Servo-Ventilation for Central Sleep Apnea in Heart Failure. Full Text available with Trip Pro

Adaptive Servo-Ventilation for Central Sleep Apnea in Heart Failure. 26886534 2016 02 19 2018 12 02 1533-4406 374 7 2016 02 18 The New England journal of medicine N. Engl. J. Med. Adaptive Servo-Ventilation for Central Sleep Apnea in Heart Failure. 689-90 10.1056/NEJMc1515007 Schäfer Astrid A Brinker Andrea A Schriever Ulf U eng Letter Comment United States N Engl J Med 0255562 0028-4793 AIM IM N Engl J Med. 2015 Sep 17;373(12):1095-105 26323938 N Engl J Med. 2016 Feb 18;374(7):691 26894248 N (...) Engl J Med. 2015 Sep 17;373(12):1166-7 26323939 Cardiovascular Diseases mortality Female Heart Failure, Systolic complications Humans Male Positive-Pressure Respiration methods Sleep Apnea, Central therapy 2016 2 18 6 0 2016 2 18 6 0 2016 2 20 6 0 ppublish 26886534 10.1056/NEJMc1515007 10.1056/NEJMc1515007#SA6

2016 NEJM

184. Notice of Retraction: Jamal SA, et al. Effect of Nitroglycerin Ointment on Bone Density and Strength in Postmenopausal Women: A Randomized Trial. JAMA. 2011;305(8):800-807. Full Text available with Trip Pro

Notice of Retraction: Jamal SA, et al. Effect of Nitroglycerin Ointment on Bone Density and Strength in Postmenopausal Women: A Randomized Trial. JAMA. 2011;305(8):800-807. 26719994 2016 02 04 2019 02 25 1538-3598 315 4 2016 Jan 26 JAMA JAMA Notice of Retraction: Jamal SA, et al. Effect of Nitroglycerin Ointment on Bone Density and Strength in Postmenopausal Women: A Randomized Trial. JAMA. 2011;305(8):800-807. 418-9 10.1001/jama.2015.18431 Eastell Richard R Metabolic Bone Centre, Northern (...) General Hospital, South Yorkshire, England. Hamilton Celeste J CJ Cummings Steven R SR San Francisco Coordinating Center, California Pacific Medical Center Research Institute, San Francisco, California. eng Retraction of Publication United States JAMA 7501160 0098-7484 Jamal SA, Hamilton CJ, Eastell R, Cummings SR. JAMA. 2011 Feb 23;305(8):800-7 21343579 Ann Pharmacother. 2016 Apr;50(4):329 26847862 2016 1 1 6 0 2016 1 1 6 0 2016 2 5 6 0 ppublish 26719994 2479463 10.1001/jama.2015.18431

2016 JAMA Controlled trial quality: uncertain

185. Treatment of Older Adults with Insomnia, Agitation, or Delirium with Benzodiazepines: Clinical Effectiveness and Guidelines

, confusion, delirium, elderly, geriatrics, hypnotics and sedatives, long-term care, mental health, nervous system, psychomotor agitation, sleep disorders, sleep initiation and maintenance disorders, sleeplessness, 80 and over, Senior, Seniors, agitated, sleep disorder, sleep dysfunction Files Rapid Response Summary with Critical Appraisal Published : January 14, 2016 Related Content Follow us: © 2019 Canadian Agency for Drugs and Technologies in Health Get our newsletter: (...) Treatment of Older Adults with Insomnia, Agitation, or Delirium with Benzodiazepines: Clinical Effectiveness and Guidelines Treatment of Older Adults with Insomnia, Agitation, or Delirium with Benzodiazepines: Clinical Effectiveness and Guidelines | CADTH.ca Find the information you need Treatment of Older Adults with Insomnia, Agitation, or Delirium with Benzodiazepines: Clinical Effectiveness and Guidelines Treatment of Older Adults with Insomnia, Agitation, or Delirium with Benzodiazepines

2016 Canadian Agency for Drugs and Technologies in Health - Rapid Review

186. Psychological interventions: Cognitive?behavioural therapy for insomnia: effective, long-lasting and safe

–3 This includes individuals with uncomplicated chronic insomnia 1 and those whose chronic insomnia is comorbid with medical or psychiatric disorders. 2 , 3 Truaer and colleagues have conducted a systematic review and meta-analysis to collect all the relevant evidence about CBT-I and quantify its overall effects. Methods of the study The data were obtained from searches of MEDLINE, EMBASE, PsycINFO, CINAHL, the Cochrane Library … Request Permissions If you wish to reuse any or all of this article (...) Psychological interventions: Cognitive?behavioural therapy for insomnia: effective, long-lasting and safe Cognitive–behavioural therapy for insomnia: effective, long-lasting and safe | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts OR managers

2016 Evidence-Based Mental Health

187. Management of insomnia disorder

, Khawaja IS, Ouellette J, Butler M, Kane RL, Wilt TJ. Management of insomnia disorder. Rockville: Agency for Healthcare Research and Quality (AHRQ). Comparative Effectiveness Review No. 159. 2015 Authors' objectives To assess the efficacy, comparative effectiveness, and harms of treatments for insomnia disorder in the general adult population and older adults. Authors' conclusions CBT-I or medical therapy with eszopiclone, zolpidem, and suvorexant improve global and sleep outcomes for insomnia disorder (...) Management of insomnia disorder Management of insomnia disorder Management of insomnia disorder Brasure M, MacDonald R, Fuchs E, Olson CM, Carlyle M, Diem S, Koffel E, Khawaja IS, Ouellette J, Butler M, Kane RL, Wilt TJ Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Brasure M, MacDonald R, Fuchs E, Olson CM, Carlyle M, Diem S, Koffel E

2016 Health Technology Assessment (HTA) Database.

188. Policy on Obstructive Sleep Apnea

of sleep- breathing disorders: A mandate for dentistry. Sleep Breath 2009;13(1):1-2. 9. Jauhar S, Orcharson R, Banham SW, Livingston E, Sherriff A, Lyons MF. The Kushida Index as a screening tool for obstructive sleep apnoea-hypopnoea syndrome. Brit Dent J 2012;212E2:1-3. 10. Polysomnography Task Force, American Sleep Disorders Association Standards of Practice Committee. Practice parameters for the indications for polysomnography and related procedures. Sleep 1997;20(6):402-22. 11. Hoffstein V. Review (...) on the diagnosis and management of childhood obstructive sleep apnea syndrome. Pediatrics 2012;130 (3):576-684. 2. Padmanabhan V, Kavitha PR, Hedge AM. Sleep disor- dered breathing in children—A review and the role of the pediatric dentist. J Clin Ped Dent 2010;35(1):15-21. 3. American Academy of Sleep Medicine. International Classification of Sleep Disorders, 3rd ed. Darien, Ill.: American Academy of Sleep Medicine; 2014:63-8. 4. Malhotra A, Owens RL. What is central sleep apnea? Respir Care 2010;55(9):1168

2016 American Academy of Pediatric Dentistry

189. Music for insomnia in adults

Media Releases 2013 Media Releases 2012 Media Releases Search Music for insomnia in adults Music for insomnia in adults Introduction In 2015 German composer Max Richter released ‘Sleep’, an eight-hour ‘lullaby for a frenetic world’ and at the world premiere in London, listeners were offered beds instead of chairs. Intervention Listening to pre-recorded music daily, either at bedtime or at some time throughout the day. Listening to music can be used alone or combined with other relaxation techniques (...) . Indication Adults with insomnia, with the aim of improving sleep quality. On the Epworth Sleep quality scale, music intervention showed a moderate effect (a 1 standard deviation improvement) in favour of intervention. Music may improve sleep by enhancing relaxation (decreasing sympathetic arousal, anxiety and stress responses) and/or acting as a distraction from stressful thoughts. Different effects may depend on the type of music used, the aetiology of the insomnia and the length and duration

2016 Handbook of Non-Drug interventions (HANDI)

190. Mandibular devices for obstructive sleep apnoea

to moderate OSA, and moderate to severe OSA when patients are intolerant of CPAP. The severity of OSA is measured using the apnoeahypopnoea index (AHI), which is the number of apnoea and hypopnoea events per hour (counted during an overnight sleep study). Mild OSA is as defined as 5–14 events per hour; moderate is 15–30; severe is >30. MADs have been shown to reduce the severity of OSA (i.e. fewer apnoea/hypopnea events per hour during sleep) and improve symptoms such as daytime sleepiness. For patients (...) Mandibular devices for obstructive sleep apnoea RACGP - Mandibular devices for obstructive sleep apnoea Search Become a student member today for free and be part of the RACGP community A career in general practice Starting the GP journey Enrolments for the 2019.1 OSCE FRACGP exams closing 29 March 2019 Fellowship FRACGP exams Research Practice Experience Program is a self-directed education program designed to support non vocationally registered doctors on their pathway to RACGP Fellowship

2016 Handbook of Non-Drug interventions (HANDI)

191. Mandibular advancement devices: obstructive sleep apnoea

Mild to moderate OSA, and moderate to severe OSA when patients are intolerant of CPAP. The severity of OSA is measured using the apnoeahypopnoea index (AHI), which is the number of apnoea and hypopnoea events per hour (counted during an overnight sleep study). Mild OSA is as defined as 5–14 events per hour; moderate is 15–30; severe is >30. MADs have been shown to reduce the severity of OSA (i.e. fewer apnoea/hypopnea events per hour during sleep) and improve symptoms such as daytime sleepiness (...) Mandibular advancement devices: obstructive sleep apnoea RACGP - Mandibular devices for obstructive sleep apnoea Search Become a student member today for free and be part of the RACGP community A career in general practice Starting the GP journey Enrolments for the 2019.1 OSCE FRACGP exams closing 29 March 2019 Fellowship FRACGP exams Research Practice Experience Program is a self-directed education program designed to support non vocationally registered doctors on their pathway to RACGP

2016 Handbook of Non-Drug interventions (HANDI)

192. An Official ATS Statement: Impact of Mild Obstructive Sleep Apnea in Adults

. There was no evidence from a single study that treatment of mild OSA reduces all-cause mortality. d The task force members identi?ed speci?c research gaps and made recommendations to address these gaps in knowledge. Introduction OSA is a major public health problem that is characterized by repetitive obstruction of the upper airway resulting in oxygen desaturation and/or arousals from sleep. The International Classi?cation of Sleep Disorders (1) de?nes OSA as the occurrence of predominantly obstructive apneas (...) (cessation of air?ow) and hypopneas (reduction in air?ow) denoted by either an apneahypopnea index (AHI; number of apneas and hypopneas per hour of sleep) of greater than or equal to 15/h or greater than or equal to 5/h accompanied by cardiovascular, neurocognitive, or metabolic consequences. General population-based studies indicate that the prevalence of OSA syndrome de?ned as AHI greater than or equal to 5/h with daytime sleepiness ranges from 3 to 7.5% in adult menandfrom2to3%inadultwomen (2–8

2016 American Thoracic Society

193. The Treatment of Central Sleep Apnea Syndromes in Adults: Practice Parameters with an Evidence-Based Literature Review and Meta-Analyses

to opioid use. Patients who are on long-acting opioids for at least 2 months appear to be at increased risk for developing CSAS. In 1.0 INTRODUCTION The central sleep apnea syndromes (CSAS) are character- ized by sleep disordered breathing associated with diminished or absent respiratory effort, coupled with the presence of symp- toms including excessive daytime sleepiness, frequent noctur- nal awakenings, or both. However, no recent evidence-based guidelines have been published. The purpose (...) correspondence to: Sherene Thomas, PhD, 2510 North Frontage Road, Darien, IL 60561; Tel: (630) 737-9700; Fax: (630) 737-9790; E-mail: sthomas@aasmnet.org The International Classification of Sleep Disorders, Second Edition (ICSD-2) distinguishes 5 subtypes of central sleep apnea syndromes (CSAS) in adults. Review of the literature suggests that there are two basic mechanisms that trigger central respiratory events: (1) post-hyperventilation cen- tral apnea, which may be triggered by a variety of clinical

2016 American Academy of Sleep Medicine

194. Management of Chronic Insomnia Disorder in Adults: A Clinical Practice Guideline From the American College of Physicians

) Insomnia is a major health care problem in the United States. It is defined as dissatisfaction with sleep quantity or quality and is associated with difficulty initiating or maintaining sleep and early-morning waking with inability to return to sleep ( ). Approximately 6% to 10% of adults have insomnia that meets diagnostic criteria ( ). Insomnia is more common in women and older adults ( , ) and can occur independently or be caused by another disease. People with the disorder often experience fatigue (...) . Older adults are more likely to report problems with waking after sleep onset (difficulty maintaining sleep) than they are to report problems with sleep onset latency (time to fall asleep). The goal of treatment for insomnia is to improve sleep and alleviate distress or dysfunction caused by the disorder. Insomnia can be managed with psychological therapy, pharmacologic therapy, or a combination of both. Psychological therapy options include cognitive behavioral therapy for insomnia (CBT-I

2016 American College of Physicians

200. Cohort study: Insomnia is associated with risk of future cardiovascular events irrespective of comorbidities

limitations in prior literature. An important methodological shortcoming was the inadequate consideration of comorbidities in several previous studies. Insomnia symptoms clearly overlap with those of depression, and could be caused by other sleep disorders, most importantly by obstructive sleep apnoea and by several somatic diseases which could increase the risk for cardiovascular diseases. Hsu and colleagues took advantage of a large nationwide health database and investigated the long-term association (...) Cohort study: Insomnia is associated with risk of future cardiovascular events irrespective of comorbidities Insomnia is associated with risk of future cardiovascular events irrespective of comorbidities | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal

2016 Evidence-Based Medicine